Sphere Medical Holding (LSE:SPHR) Interest Expense : £0.00 Mil (TTM As of Dec. 2016)

View and export this data going back to 2011. Start your Free Trial

What is Sphere Medical Holding Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Sphere Medical Holding's interest expense for the six months ended in Dec. 2016 was £ 0.00 Mil. Its interest expense for the trailing twelve months (TTM) ended in Dec. 2016 was £0.00 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Sphere Medical Holding's Operating Income for the six months ended in Dec. 2016 was £ -2.50 Mil. Sphere Medical Holding's Interest Expense for the six months ended in Dec. 2016 was £ 0.00 Mil. Sphere Medical Holding has no long-term debt ⁽¹⁾. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

(1) Note: An indication of "no long-term debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

Sphere Medical Holding Interest Expense Historical Data

The historical data trend for Sphere Medical Holding's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sphere Medical Holding Interest Expense Chart

Sphere Medical Holding Annual Data

Trend

Dec08

Dec09

Dec10

Dec11

Dec12

Dec13

Dec14

Dec15

Dec16

Interest Expense

Get a 7-Day Free Trial

Sphere Medical Holding Semi-Annual Data
	Dec11	Jun12	Dec12	Jun13	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16
Interest Expense	Get a 7-Day Free Trial						-	-	-	-	-

Sphere Medical Holding Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Dec. 2016 adds up the semi-annually data reported by the company within the most recent 12 months, which was £0.00 Mil.

Sphere Medical Holding (LSE:SPHR) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Sphere Medical Holding's Interest Expense for the six months ended in Dec. 2016 was £0.00 Mil. Its Operating Income for the six months ended in Dec. 2016 was £-2.50 Mil. And its Long-Term Debt & Capital Lease Obligation for the six months ended in Dec. 2016 was £0.00 Mil.

Sphere Medical Holding's Interest Coverage for the quarter that ended in Dec. 2016 is calculated as

Sphere Medical Holding had no long-term debt ⁽¹⁾.

The higher the ratio, the stronger the company's financial strength is.

Good Sign:

Sphere Medical Holding PLC has no debt.

Sphere Medical Holding (LSE:SPHR) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Sphere Medical Holding PLC (LSE:SPHR) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

Harston Mill, Harston, Cambridge, GBR, CB22 7GG

Website

http://www.spheremedical.com

Sphere Medical Holding Ltd is a UK-based company which is engaged in research and development, manufacturing and sale of medical monitoring and diagnostic equipment within the medical device area. It focuses on developing the Proxima platform for measuring blood gases, electrolytes and metabolites. Proxima is an in-line patient dedicated arterial blood analyser which supports frequent measurements at critical times. It markets its product (Proxima) to critical care market which includes ICU (Intensive Care Unit) and OR (Operating Room). The company's products are used in medical applications, enabling faster clinical decision-making and improved patient outcomes. It operates is business in single reporting segment of Medical devices. Most of the company's revenue comes from Europe.